Cardio-oncology, An Issue of Cardiology Clinics, 1st Edition
Authors :
Eric H. Yang & Ashley F. Stein-Merlob
Date of Publication: 11/2024
In this issue of Cardiology Clinics, guest editors Drs. Eric H. Yang and Ashley F. Stein-Merlob bring their considerable expertise to the topic of Cardio-oncology. Top experts discuss key topics such as anthracycline-induced cardiotoxicity; cardiac c ...view more
In this issue of Cardiology Clinics, guest editors Drs. Eric H. Yang and Ashley F. Stein-Merlob bring their considerable expertise to the topic of Cardio-oncology. Top experts discuss key topics such as anthracycline-induced cardiotoxicity; cardiac complications of immunotherapy: immune checkpoint inhibitors and CAR T cell therapy; advances in diagnosis and treatment of amyloid cardiomyopathy; guidelines in cardio-oncology; and more.
In this issue of Cardiology Clinics, guest editors Drs. Eric H. Yang and Ashley F. Stein-Merlob bring their considerable expertise to the topic of Cardio-oncology. Top experts discuss key topics such as anthracycline-induced cardiotoxicity; cardiac complications of immunotherapy: immune checkpoint inhibitors and CAR T cell therapy; advances in diagnosis and treatment of amyloid cardiomyopathy; guidelines in cardio-oncology; and more.
Key Features
Contains 18 relevant, practice-oriented topics including permissive cardiotoxicity; advances in imaging of cardiotoxicity; management of cancer therapy-related hypertension; cardiac complications of radiation therapy; health disparities in cardio-oncology; and more.
Provides in-depth clinical reviews on cardio-oncology, offering actionable insights for clinical practice.
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Author Information
Edited by Eric H. Yang, M.D., FACC, FASE, FAHA, Associate Clinical Professor of Medicine, Director, UCLA Cardio-Oncology Program,Associate Program Director, UCLA/Olive View/West LA VA Cardiovascular Diseases Fellowship, Division of Cardiology, Department of Medicine, University of California, Los Angeles and Ashley F. Stein-Merlob, MD, Division of Cardiology, Department of Medicine, University of California at Los Angeles, Los Angeles, CA, USA
Bring it with you - The Bookshelf app allows you to access books on your laptop, tablet or mobile, so your ebooks go where ever you are - online or offline.
Take notes - Highlight, bookmark and take notes and highlights automatically stay in sync no matter where you make them.
Listen to eBooks - When you need to go screenless, the Text-to-speech tool will read your book aloud.
Powerful search - The searching capabilities allow you to search keywords through all your eBooks, the entire Bookshelf Library and well as on Wikipedia.
Ecological - Manage your environmental impact with paperless books.
How to read your VitalSource eBooks
Purchase your VitalSource eBook on the Elsevier Health site
https://www.eu.elsevierhealth.com/cardio-oncology-an-issue-of-cardiology-clinics-9780443246845.html323000Cardio-oncology, An Issue of Cardiology Clinicshttps://www.eu.elsevierhealth.com/media/catalog/product/9/7/9780443246845.jpg65.2486.99EURInStock/Medicine and Surgery/Cardiology/Clinics Review Articles98425612837174549828In this issue of <i>Cardiology Clinics</i>, guest editors Drs. Eric H. Yang and Ashley F. Stein-Merlob bring their considerable expertise to the topic of <b>Cardio-oncology</b>. Top experts discuss key topics such as anthracycline-induced cardiotoxicity; cardiac complications of immunotherapy: immune checkpoint inhibitors and CAR T cell therapy; advances in diagnosis and treatment of amyloid cardiomyopathy; guidelines in cardio-oncology; and more. In this issue of <i>Cardiology Clinics</i>, guest editors Drs. Eric H. Yang and Ashley F. Stein-Merlob bring their considerable expertise to the topic of <b>Cardio-oncology</b>. Top experts discuss key topics such as anthracycline-induced cardiotoxicity; cardiac complications of immunotherapy: immune checkpoint inhibitors and CAR T cell therapy; advances in diagnosis and treatment of amyloid cardiomyopathy; guidelines in cardio-oncology; and more.00add-to-cart97804432468452024ProfessionalEdited by Eric H. Yang, M.D., FACC, FASE, FAHA and Ashley F. Stein-Merlob, MD20251Book178w x 254h (7.00" x 10.00")Elsevier24021 Nov 2024PRINT ON DEMAND - DELIVERY CAN TAKE UP TO 10 DAYSEdited by <STRONG>Eric H. Yang</STRONG>, M.D., FACC, FASE, FAHA, Associate Clinical Professor of Medicine, Director, UCLA Cardio-Oncology Program,Associate Program Director, UCLA/Olive View/West LA VA Cardiovascular Diseases Fellowship, Division of Cardiology, Department of Medicine, University of California, Los Angeles and <STRONG>Ashley F. Stein-Merlob</STRONG>, MD, Division of Cardiology, Department of Medicine, University of California at Los Angeles, Los Angeles, CA, USAClinicsThe Clinics: Internal MedicineNoNoNoNoPlease SelectPlease SelectPlease Select
